Skip to content
← Full study record

NCT00477971 · MORE INFO

Limitations, agreements, and source contact

Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis · Source last updated 2016-05-17

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
gertz.morie@mayo.edu
organization
Mayo Clinic
title
Dr. Morie Gertz
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
gertz.morie@mayo.edu
organization
Mayo Clinic
title
Dr. Morie Gertz

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice